We are analyzing https://link.springer.com/article/10.1007/s10142-025-01586-1.

Title:
EXO1 as a potential biomarker for prognosis, immune infiltration, and immunotherapy in pan-cancer analysis | Functional & Integrative Genomics
Description:
Functional & Integrative Genomics - Human EXO1 is a 5
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

cancer, article, pubmed, exo, cell, carcinoma, google, scholar, immune, immunotherapy, wang, cas, central, guangxi, role, potential, prognosis, medicine, adenocarcinoma, analysis, jikang, dna, repair, tumor, content, information, biomarker, exonuclease, cancers, prognostic, genomic, personalized, access, cells, medical, privacy, cookies, data, research, pancancer, huang, study, rna, zhang, mol, university, springer, journal, publish, search,

Topics {✒️}

month download article/chapter cell cycle-dependent control analyzed exo1-related genes skin cutaneous melanoma multi-omics analysis reveals reduced class-switch recombination tumor-infiltrating immune cells related subjects glioma tcga-hnsc kich + kirc + kirp damage signaling decisions full article pdf maintaining replication forks privacy choices/manage cookies tumor immune microenvironment pan-kidney cohort cell cycle regulation influence drug resistance cholangiocarcinoma tcga-coad mesothelioma tcga-ov paraganglioma tcga-prad sarcoma tcga-stad thymoma tcga-ucec tumour immunotherapy defined human system offering valuable insights pan-cancer analysis dna repair deficiencies guangxi key laboratory pan-cancer roles dna end resection increased cancer susceptibility article wang long ssdna gaps youth foundation project checkpoint-defective cells immune checkpoint therapy immune checkpoint blockade cancer patient prognosis high exo1 expression exo1 expression levels elevated exo1 expression hepatocellular carcinoma personalized cancer therapy european economic area utilizing multiple databases significantly higher levels crucial biological processes altered somatic hypermutation counteracts fork reversal

Schema {🗺️}

WebPage:
      mainEntity:
         headline:EXO1 as a potential biomarker for prognosis, immune infiltration, and immunotherapy in pan-cancer analysis
         description:Human EXO1 is a 5' → 3' exonuclease that plays a critical role in regulating cell cycle checkpoints, maintaining replication forks and participating in post-replication DNA repair pathways. Previous studies have highlighted the importance of EXO1 in cancers such as liver and breast cancer. However, there is a gap in the comprehensive analysis of EXO1 in a wide range of cancers, and its precise role in cancer patient prognosis and immune response remains unclear. This study aims to systematically investigate the potential associations between EXO1, immune infiltration and prognostic value in different cancer types and to gain a deeper understanding of its mechanisms of action.We conducted a comprehensive investigation into the overarching role of EXO1 across various cancers by utilizing multiple databases. Our analysis encompassed scrutinizing EXO1 expression and evaluating its correlation with clinical survival, immune checkpoints, Tumor Stemness Score, Prognostic Value, immunomodulators, genomic profiles, immunological characteristics, immunotherapy, and functional enrichment. EXO1 is expressed in various normal tissues and at significantly higher levels in most tumors compared to non-tumor tissues. High EXO1 expression is associated with poor prognosis in certain cancers. Genetic mutations and RNA modifications of EXO1 were also investigated, as well as its correlation with tumor immunity and genomic stability. We investigated the potential role of EXO1 in immunotherapy and identified differing drug responses based on EXO1 expression levels in Skin Cutaneous Melanoma (SKCM), which holds promise for personalized treatment. Furthermore, we analyzed EXO1-related genes and pathways, revealing its potential involvement in crucial biological processes such as DNA repair and cell cycle regulation. These findings provide a comprehensive understanding of the role of EXO1 in cancer initiation and progression, offering valuable insights for personalized cancer therapy and precision medicine. This study highlights the diverse functions of EXO1 in cancer, including its involvement in cancer initiation, prognosis, immune regulation, and response to immunotherapy. These findings provide valuable insights into the potential of EXO1 as a biomarker and therapeutic target, as well as its role in determining treatment response in cancer management. This information is crucial for guiding personalized cancer therapy and precision medicine.
         datePublished:2025-04-11T00:00:00Z
         dateModified:2025-04-11T00:00:00Z
         pageStart:1
         pageEnd:16
         sameAs:https://doi.org/10.1007/s10142-025-01586-1
         keywords:
            EXO1
            Prognosis
            Immune infiltration
            Immunological biomarker
            Immunotherapy
            Cell Biology
            Plant Genetics and Genomics
            Microbial Genetics and Genomics
            Biochemistry
            general
            Bioinformatics
            Animal Genetics and Genomics
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig8_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig9_HTML.png
         isPartOf:
            name:Functional & Integrative Genomics
            issn:
               1438-7948
               1438-793X
            volumeNumber:25
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jikang Wang
               affiliation:
                     name:Guangxi Medical University
                     address:
                        name:Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
                     name:Guangxi Medical University
                     address:
                        name:Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
                     name:Guangxi Medical University
                     address:
                        name:Research Centre for Regenerative Medicine, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Fubo Wang
               affiliation:
                     name:Guangxi Medical University
                     address:
                        name:Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Haoxuan Huang
               affiliation:
                     name:Guangxi Medical University
                     address:
                        name:Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:EXO1 as a potential biomarker for prognosis, immune infiltration, and immunotherapy in pan-cancer analysis
      description:Human EXO1 is a 5' → 3' exonuclease that plays a critical role in regulating cell cycle checkpoints, maintaining replication forks and participating in post-replication DNA repair pathways. Previous studies have highlighted the importance of EXO1 in cancers such as liver and breast cancer. However, there is a gap in the comprehensive analysis of EXO1 in a wide range of cancers, and its precise role in cancer patient prognosis and immune response remains unclear. This study aims to systematically investigate the potential associations between EXO1, immune infiltration and prognostic value in different cancer types and to gain a deeper understanding of its mechanisms of action.We conducted a comprehensive investigation into the overarching role of EXO1 across various cancers by utilizing multiple databases. Our analysis encompassed scrutinizing EXO1 expression and evaluating its correlation with clinical survival, immune checkpoints, Tumor Stemness Score, Prognostic Value, immunomodulators, genomic profiles, immunological characteristics, immunotherapy, and functional enrichment. EXO1 is expressed in various normal tissues and at significantly higher levels in most tumors compared to non-tumor tissues. High EXO1 expression is associated with poor prognosis in certain cancers. Genetic mutations and RNA modifications of EXO1 were also investigated, as well as its correlation with tumor immunity and genomic stability. We investigated the potential role of EXO1 in immunotherapy and identified differing drug responses based on EXO1 expression levels in Skin Cutaneous Melanoma (SKCM), which holds promise for personalized treatment. Furthermore, we analyzed EXO1-related genes and pathways, revealing its potential involvement in crucial biological processes such as DNA repair and cell cycle regulation. These findings provide a comprehensive understanding of the role of EXO1 in cancer initiation and progression, offering valuable insights for personalized cancer therapy and precision medicine. This study highlights the diverse functions of EXO1 in cancer, including its involvement in cancer initiation, prognosis, immune regulation, and response to immunotherapy. These findings provide valuable insights into the potential of EXO1 as a biomarker and therapeutic target, as well as its role in determining treatment response in cancer management. This information is crucial for guiding personalized cancer therapy and precision medicine.
      datePublished:2025-04-11T00:00:00Z
      dateModified:2025-04-11T00:00:00Z
      pageStart:1
      pageEnd:16
      sameAs:https://doi.org/10.1007/s10142-025-01586-1
      keywords:
         EXO1
         Prognosis
         Immune infiltration
         Immunological biomarker
         Immunotherapy
         Cell Biology
         Plant Genetics and Genomics
         Microbial Genetics and Genomics
         Biochemistry
         general
         Bioinformatics
         Animal Genetics and Genomics
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig8_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10142-025-01586-1/MediaObjects/10142_2025_1586_Fig9_HTML.png
      isPartOf:
         name:Functional & Integrative Genomics
         issn:
            1438-7948
            1438-793X
         volumeNumber:25
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jikang Wang
            affiliation:
                  name:Guangxi Medical University
                  address:
                     name:Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
                  name:Guangxi Medical University
                  address:
                     name:Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
                  name:Guangxi Medical University
                  address:
                     name:Research Centre for Regenerative Medicine, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Fubo Wang
            affiliation:
                  name:Guangxi Medical University
                  address:
                     name:Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Haoxuan Huang
            affiliation:
                  name:Guangxi Medical University
                  address:
                     name:Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Functional & Integrative Genomics
      issn:
         1438-7948
         1438-793X
      volumeNumber:25
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Guangxi Medical University
      address:
         name:Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:Guangxi Medical University
      address:
         name:Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:Guangxi Medical University
      address:
         name:Research Centre for Regenerative Medicine, Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:Guangxi Medical University
      address:
         name:Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:Guangxi Medical University
      address:
         name:Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jikang Wang
      affiliation:
            name:Guangxi Medical University
            address:
               name:Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
            name:Guangxi Medical University
            address:
               name:Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
            name:Guangxi Medical University
            address:
               name:Research Centre for Regenerative Medicine, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      name:Fubo Wang
      affiliation:
            name:Guangxi Medical University
            address:
               name:Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Haoxuan Huang
      affiliation:
            name:Guangxi Medical University
            address:
               name:Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Nanning, China
      name:Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, China
      name:Research Centre for Regenerative Medicine, Guangxi Medical University, Nanning, China
      name:Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China
      name:Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(87)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.47s.

LINK . SPRINGER . COM {}